Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist

Brain Research Bulletin

Volumn 59, Issue 6, 2003, Pages 513-521

  Dawson, Lee A ^a,b   Nguyen, Huy Q ^a   Li, Ping ^a  

^a Neuroscience Research   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 Chloro N (4 methoxy 3 piperazin 1 yl phenyl) 3 methyl 2 benzothiophenesulfonamide (SB 271046); Microdialysis; Striatum

Indexed keywords

5 CHLORO N (METHOXY 3 PIPERAZIN 1 YLPHENYL) 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; AMPHETAMINE; DOPAMINE; RECEPTOR BLOCKING AGENT; SEROTONIN; SEROTONIN 6 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG POTENTIATION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DRUG SYNERGISM; EXTRACELLULAR SPACE; GLUTAMIC ACID; MALE; MICRODIALYSIS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SULFONAMIDES; THIOPHENES;

EID: 0037441579     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(02)00967-X     Document Type: Article

References (41)

1. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
2. 6 receptor antagonist, Ro 04-6790, in rats. Br. J. Pharmacol. 126:1999;1537-1542.
3. 4 receptor subtype involvement in the enhancement of striatal DA release induced by serotonin: A microdialysis study in halothane-anaethetised rats. Neuropharmacology. 34:1995;269-279.
4. 6 receptors in nigro-striatal function in rodents. Br. J. Pharmacol. 125:1998;1562-1566.
5. 6 receptor in the rat brain: A study using antisense oligonucleotides. J. Pharmacol. Exp. Ther. 274:1995;173-180.
6. 6 receptor antagonist. J. Med. Chem. 42:1999;202-205.
7. A and glutamate receptors. J. Neurosci. 21:2001;9917-9929.
8. 6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology. 25:2001;662-668.
9. 6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br. J. Pharmacol. 130:2000;23-26.
10. 1A receptor antagonists on fluoxetine-induced changes in serotonin in rat frontal cortex. Eur. J. Pharmacol. 345:1998;41-46.
11. Dawson L.A., Stow J.M., Palmer A.M. Improved method for the measurement of glutamate and aspartate using capillary electrophoresis with laser induced fluorescence detection and its application to brain microdialysis. J. Chromatogr. 694:1997;455-460.
12. 4 receptors indirectly enhances in vivo dopamine release in the rat striatum. J. Neurochem. 68:1997;195-203.
13. De Deurwaerdere P., Spampinato U. Role of serotonin2A and serotonin 2B/C receptor subtypes in the control of accumbal and striatal dopamine release elicited by in vivo dorsal raphe nucleus electrical stimulation. J. Neurochem. 73:1999;1033-1042.
14. Dewey S.L., Smith G.S., Logan J., Alexoff D., Ding Y.-S., King P., Pappas N., Brodie J.D., Ashby C.R. Serotonin modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15:1995;821-829.
15. 6 receptor antagonism potentiates the behavioural and neurochemical effects of amphetamine but not cocaine. Neuropharmacology. 42:2002;170-180.
16. 6 receptor-like material in the rat central nervous system. Brain Res. 746:1997;207-219.
17. Hernandez L., Lee F., Hoebel B.G. Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: Increase in extracellular dopamine and serotonin. Brain Res. Bull. 19:1987;623-628.
18. Herve D., Pickel V.M., Joh T.H., Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res. 435:1987;71-83.
19. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72:1992;165-229.
20. Kapur S., Remington G. Serotonin-dopamine interation and its relevance to Schizophrenia. Am. J. Psychiatr. 153:1996;466-476.
21. Maurice N., Deniau J.-M., Glowinski J., Thierry A.-M. Relationships between the prefrontal cortex and the basal ganglia in the rat: Physiology of the cortico-nigral circuits. J. Neurosci. 19:1999;4674-4681.
22. Monsma J.R., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43:1993;320-327.
23. Mora F., Porras A. Effects of amphetamine on the release of excitatory amino acid neurotransmitters in the basal ganglia of the conscious rat. J. Physiol. Pharmacol. 71:1993;248-351.
24. Needergaard S., Bolam J.P., Greenfield S.A. Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature. 333:1988;174-177.
25. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.
26. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain IV: Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
27. Pehek E.A. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. J. Pharmacol. Exp. Ther. 289:1999;14-23.
28. 2B/C receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology. 26:2002;311-324.
29. 6 antagonist SB-271046. Br. J. Pharmacol. 127:1999;22P.
30. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J. Jr., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268:1994;1403-1410.
31. 6 receptor antagonist. Br. J. Pharmacol. 130:2000;1606-1612.
32. 6 receptor antagonist. Br. J. Pharmacol. 127:1999;21P.
33. 6) receptor: Molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193:1993;268-276.
34. 6 receptors: Functional correlates and potential therapeutic indications. Behav. Pharmacol. 10:1999;S86.
35. 6 receptor null mice. In: Proceedings of the 4th IUPHAR satellite meeting on serotonin. Rotterdam: S1.2; 1998.
36. 2 dopamine receptor binding in humans measured with positron emission tomography. Psychopharmacology. 126:1996;277-280.
37. 2 receptor antagonist, activates midbrain dopamine neurones by blocking serotonergic inhibition. Psychopharmacology. 98:1989;45-50.
38. Ward R.P., Hamblin M.W., Lachowicz J.E., Hoffman B.J., Sibley D.R., Dorsa D.M. Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience. 64:1995;1105-1111.
39. 6 receptors on GABAergic but not cholinergic neurones in the adult rat brain. Brain Res. Bull. conference: Serotonin from the molecule to the clinic 95; 2000.
40. Yadid G., Karel P., Kopin J.J., Goldstien D.S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270:1994;1158-1165.
41. 6 receptor subtype in the rat brain. Life Sci. 62:1998;1473-1477.